IDF Combat Mortality Drops as US Army Studies Israeli Medical Advances
JERUSALEM, June 12, The Israel Defense Forces reported a battlefield mortality rate of 7.1 percent during the 2023 conflict, a sharp decline from the 15 percent recorded during the 2006 war with Hezbollah. An April 2026 U.S. military report titled "Israeli Defense Force Medical Lessons Learned" details how the American military is absorbing these Israeli advances to improve its own combat casualty care.
JERUSALEM, June 12, The Israel Defense Forces reported a battlefield mortality rate of 7.1 percent during the 2023 conflict, a sharp decline from the 15 percent recorded during the 2006 war with Hezbollah. An April 2026 U.S. military report titled "Israeli Defense Force Medical Lessons Learned" details how the American military is absorbing these Israeli advances to improve its own combat casualty care.
Fox News Digital spoke with a senior IDF medical specialist who explained that the reduction in deaths stems from specific operational changes implemented during the war in Gaza. The specialist noted that in 2006, advanced life support took 15 to 20 minutes to reach a casualty. In the current conflict, that time has been reduced to immediate response or within four minutes. This speed is enabled by placing a doctor in every company and using helicopters to transport wounded soldiers to medical facilities.
The IDF also changed its approach to hemorrhage control. Since 2013, there has been an emphasis on using blood products to stop bleeding. The IDF was the first medical organization to use plasma at the point of injury rather than salt and water. First responders carried blood in coolers on their backs to control hemorrhaging, a method that saved significant numbers of soldiers. Additionally, the IDF implemented a system where patient data is transmitted over technical networks, allowing every relevant medical officer in the chain of command to see the same information in real time.
The U.S. Army study, which spans 78 pages, highlights the need for the American military to avoid the "painful process of transformation" that Israel underwent. The report states that possessing clinical and tactical skills is insufficient without proactive public health measures, including bio-surveillance and forward-positioned preventive medicine teams. An IDF spokesman confirmed that the U.S. Army study was a joint collaboration and that American officers traveled to Israel to learn from IDF emergency health care providers.
Dr. Marc Siegel, a senior medical analyst for Fox News and a clinical professor of medicine at NYU Langone Medical Center, stated that battlefield advances developed in Israel, including surgical techniques and burn treatments like Nexobrid, are fueling medical advances worldwide. The IDF Medical Corps adapted its capabilities during the war, focusing on casualty evacuation and providing treatment under fire in challenging terrain. The data from these operations now serves as a primary reference for U.S. military planning in combat medicine.